Monoclonal Antibodies in Myeloma

Clinical Advances in Hematology & Oncology Volume 13, Issue 9, September 2015 Pia Sondergeld, PhD, Niels W. C. J. van de Donk, MD, PhD, Paul G. Richardson, […]

New Insights Into Hematopoietic Stem Cell Transplantation for Chronic Lymphocytic Leukemia: A 2015 Perspective

Fabienne McClanahan, MD, PhD, and John Gribben, MD, DSc, FRCP, FRCPath, FMedSci Dr McClanahan is a Clinical Research Fellow in the Centre for Haemato-Oncology at the […]

Is There a Clinical Role for Molecular Phenotyping in Atypical Presentation of Metastatic Castration-Resistant Prostate Cancer?

Now that our understanding of potentially actionable mutations has increased, is it time for physicians to look into molecular phenotyping for their patients with metastatic castration-resistant […]

FLT3 Inhibitors for Acute Myeloid Leukemia

Jeffrey E. Lancet, MD Senior Member and Professor of Oncologic Sciences Moffitt Cancer Center University of South Florida College of Medicine Tampa, Florida   H&O What […]

The Timing of Radium-223 Therapy in Castration-Resistant Prostate Cancer

Clinical Advances in Hematology & Oncology Volume 13, Issue 9, September 2015 Oliver Sartor, MD LaBorde Professor for Cancer Research Medical Director Tulane Cancer Center Departments of […]

Contraception in Women With Hereditary Thrombophilic Defects

Michiel Coppens, MD, PhD Internist, Vascular Medicine Academic Medical Center Amsterdam, The Netherlands H&O How common is thrombophilia in women of childbearing age? MC The term thrombophilia […]

The Value and Effectiveness of Angiogenesis Inhibitors for Colorectal Cancer

Alan P. Venook, MD The Madden Family Distinguished Professor of Medical Oncology and Translational Research School of Medicine University of California, San Francisco   H&O What […]

What Is the Optimal Way to Evaluate Quality of Life in Breast Cancer Trials?

Patricia A. Ganz, MD Professor of Medicine David Geffen School of Medicine at UCLA Los Angeles, California   H&O What are the main quality-of-life issues faced […]

September News

Hem/Onc News By Devon Schuyler Use of Intraperitoneal Chemotherapy in Ovarian Cancer Is Limited Fewer than half of women with stage III ovarian cancer receive intraperitoneal […]

Letter From the Editor: What I Did On My Summer Vacation

My wife and I recently returned from our remarkable, 2-week, active summer vacation—one that I highly recommend.  The journey began in Berlin, where we met some […]

Back to Archive